EP 0772449 A1 19970514 - PHARMACEUTICAL COMPOSITIONS COMPRISING A CHIMAERIC TNF BINDING PROTEIN
Title (en)
PHARMACEUTICAL COMPOSITIONS COMPRISING A CHIMAERIC TNF BINDING PROTEIN
Title (de)
PHARMATEUTISCHE ZUSAMMENSETZUNGEN ENTHALTENDE EIN CHIMÄZES TNF-BINDENDES PROTEIN
Title (fr)
COMPOSITIONS PHARMACEUTIQUES COMPRENANT UNE PROTEINE CHIMERE LIANT LE FACTEUR DE NECROSE TUMORALE
Publication
Application
Priority
- EP 95926902 A 19950715
- EP 9502788 W 19950715
- EP 94111455 A 19940722
Abstract (en)
[origin: WO9603141A1] The present invention is directed to the use of a chimaeric TNF binding protein which comprises a soluble part of the human p55- or the p75-TNF-receptor and all or parts of the constant domains of the heavy or light chain of human immunoglobulin or of a pharmaceutically acceptable salt thereof for the preparation of a pharmaceutical composition for the treatment of autoimmune diseases.
IPC 1-7
IPC 8 full level
A61K 38/00 (2006.01); A61K 38/17 (2006.01); A61K 39/395 (2006.01); A61P 25/00 (2006.01); A61P 37/00 (2006.01); C07K 14/715 (2006.01); C07K 16/24 (2006.01); C07K 19/00 (2006.01)
CPC (source: EP)
A61P 25/00 (2017.12); A61P 37/00 (2017.12); C07K 14/7151 (2013.01); A61K 38/00 (2013.01); C07K 2319/00 (2013.01)
Citation (search report)
See references of WO 9603141A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9603141 A1 19960208; AU 3111995 A 19960222; BR 9508419 A 19971118; CA 2195665 A1 19960208; CZ 19397 A3 19970611; CZ 283219 B6 19980218; EP 0772449 A1 19970514; FI 970247 A0 19970121; FI 970247 A 19970121; HU T76666 A 19971028; JP H09508140 A 19970819; NO 970264 D0 19970121; NO 970264 L 19970324; PL 318501 A1 19970623
DOCDB simple family (application)
EP 9502788 W 19950715; AU 3111995 A 19950715; BR 9508419 A 19950715; CA 2195665 A 19950715; CZ 19397 A 19950715; EP 95926902 A 19950715; FI 970247 A 19970121; HU 9700180 A 19950715; JP 50542196 A 19950715; NO 970264 A 19970121; PL 31850195 A 19950715